News

INNEXIS announces further site acquisition in Austria

Starkes Signal für den klinischen Forschungsstandort Österreich: LBG erhält 6,5 Millionen Euro vom Fonds Zukunft Österreich

TAG Therapeutics announces publication in Nature Aging providing further evidence for efficacy of the TELOBLOCK approach

BMFWF: 31,6 Mio. Euro für den Forschungsstandort: Österreich behauptet sich in der europäischen Spitzenforschung

Fraunhofer Austria: Kürzere OP-Zeiten bei Leberkrebs dank neuer Analyse-Methode

Graph Therapeutics Brings Total Funding to Over $10 Million to Advance Therapeutics Programs in Inflammation and Immunology

MedUniVienna: Testing cancer treatments in the body’s own tumour microenvironment

MedUni Vienna: Neural stimulation and exoskeletons improve hand function following neurological injuries

Wundheilung: LBG- und BOKU-Forschung zeigt schnelle Zellalterung als zentralen Teil der Heilung

F2G and Shionogi announce positive topline results from global Phase 3 OASIS study evaluating oral olorofim versus AmBisome® followed by Standard of Care in patients with invasive aspergillosis

SOMAREALITY secures over €3 million in an oversubscribed Series A round led by Catalyst Romania to become the world’s first full cognitive insights solution based solely on eye tracking

MedUni Vienna: Memory cells in the oral mucosa protect against viruses

Hattmannsdorfer/Gerzabek: CDG-Preis 2026 für Paradigmenwechsel in den Life-Sciences

PHARMIG: Arzneimittel vor Hitze schützen

IMP: Separating signal from noise: How cells decide the fate of RNA

MedUni Vienna: Colorectal Cancer Research Is Placing Greater Emphasis on Immune Cells

PIUR IMAGING: Kevin Goodwin joins as Strategic Advisor to support U.S. expansion

AIT entwickelt nachhaltige Biosensoren zur Krebserkennung

AIT: Sustainable Biosensors for More Efficient Cancer Detection

Complex Pharmaceuticals: Verdoppelung der Werksfläche am Standort Niederösterreich